News > The 3-Step Safety System for Medication-Related Osteonecrosis of the Jaw (MRONJ)

How to confidently treat patients receiving antiresorptive medications

Connect with:

• Internationally Awarded Professor Ourania Nicolatou-Galitis,
  Member of the European Expert Panel on Osteonecrosis
  (Medication-Related Osteonecrosis of the Jaw – MRONJ) and
  Former President of the Bone Study Group of the Multinational Association of Supportive Care in Cancer / International Society of Oral Oncology (MASCC/ISOO)

• Dimitra Galiti, PhD in Diagnostic and Oral Radiology,
  National and Kapodistrian University of Athens;
  Master’s degree in Oral Diagnostic Sciences (magna cum laude), KU Leuven, Belgium;
  Recipient of the MASCC/ISOO Young Investigator Award

They will reveal the exact protocol used to safely treat patients on antiresorptive medications with zero cases of MRONJ—and how you can start doing the same as early as this week.

What you will learn in the webinar

✔️ The MRONJ System
A 3-step approach that shows you which patients you can safely treat

✔️ The Osteonecrosis Risk Assessment Table
So you can decide within minutes whether to proceed, modify treatment, or refer

✔️ When tooth extraction protects the patient instead of harming them
And how to recognize early signs of osteonecrosis

✔️ The atraumatic extraction protocol
Safely applied in patients receiving antiresorptive therapy

✔️ Clinical cases
To see how real-life decisions are made in practice

✔️ The documentation protocol
That protects you both clinically and legally

✔️ What you can implement immediately in your dental practice